GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Net Interest Margin (Bank Only) %

BLIS Technologies (NZSE:BLT) Net Interest Margin (Bank Only) %


View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.


BLIS Technologies Business Description

Industry
Traded in Other Exchanges
N/A
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).